PRHSX. Some of my contenders were: TR 10 yr 15yr GILD 26.87% 29.71% Nope no yield VRX 30.84% 15.53% Nope no yield ALXN 40.44% 19.21% Nope no yield PCYC 42.80% 12.91% Nope no yield I could go on but I think you get the idea so please
May 6 (Reuters) - The hefty premium Alexion Pharmaceuticals Inc has agreed to pay to acquire Synageva BioPharma Corp highlights how the popularity of so-called orphan drug makers is leading to valuations many investors now deem frothy.
May 6 (Reuters) - Drugmaker Alexion Pharmaceuticals Inc said it would buy Synageva BioPharma Corp for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic...
politicians. But that alone won’t stop inversions and possible future candidates with 45% or more revenues from overseas include ALXN , IPG, JCI, OI, MON . For the week , Dow +0.37% , SP500 +0.33% , Nasdaq Comp +0.42% , Russell 2000 +1.48
guidance for 2014 of $4.75-4.85 (from $4.37-$4.47) was significantly above our expectations of $4.45. While ALXN maintained its revenue guidance of $2.15-$2.17 billion, profitability improvements are driven by guidance for cost of
market performance relative to sectors such as IT that require lesser capex. Some highflyers sank last week, e.g. biotechs [ ALXN , CELG, GILD, REGN ] and other momentum favorites [ GMCR, FB, TWTR, P, YELP, NFLX, BIDU ]; fears of higher rates and
FOXA 24 45 Media-Diversified Union Pacific UNP 23 23 Railroads LinkedIn LNKD 22 94 Internet Content & Info Alexion Pharmaceuticals ALXN 21 71 Biotech Amgen AMGN 21 22 Biotech Costco COST 21 44 Discount Stores Microsoft MSFT 21 3 Software-Infrastructure
companies that are at least 50% owned by mutual funds brings up a different list that includes companies such as Alexion Pharmaceuticals ALXN , Chipotle Mexican Grill CMG, Illumina ILMN, Lululemon Athletica LULU, and Moody's MCO. The fact that
(Reuters) - Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last...
Alexion ALXN reported second-quarter results that put it on track to meet our expectations for the full year, and we're maintaining our